Clinical Trial Update: A Study for Dacogen Treatment in Patients With Myelodysplastic Syndrome

View source ↗

Summary

A clinical trial evaluating Dacogen (decitabine) in patients with myelodysplastic syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndrome

Drugs mentioned

• Dacogen (decitabine)

Snippet

Sponsor: Janssen Korea, Ltd., Korea | Conditions: Myelodysplastic Syndrome | Status: COMPLETED